Rujia Zheng
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Network pharmacology of Sijunzi decoction in pancreatic cancer.
Journal: Chinese clinical oncology
Published: June 11, 2026
Metabolism-programming mRNA-lipid nanoparticles remodel the immune microenvironment to improve immunotherapy against MAFLD.
Journal: Science translational medicine
Published: December 03, 2025
Network pharmacology of Sijunzi decoction in pancreatic cancer.
Journal: Chinese clinical oncology
Published: December 03, 2025
Chrysosplenetin-induced TMED3 aggregation triggers unfolded protein response in pancreatic cancer.
Journal: EMBO molecular medicine
Published: September 05, 2025
Predicting tumor micronecrosis in hepatocellular carcinoma using pretreatment contrast-enhanced CT radiomics model: a multi-center study.
Journal: NPJ precision oncology
Published: April 17, 2025
Nano-enabled repurposing of Benproperine phosphate enhances pancreatic Cancer chemotherapy through lethal autophagy arrest and immune activation.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: March 30, 2025
Tumor-associated CD19+ macrophages induce immunosuppressive microenvironment in hepatocellular carcinoma.
Journal: Nature communications
Published: March 22, 2025
The Cancer Antioxidant Regulation System in Therapeutic Resistance.
Journal: Antioxidants (Basel, Switzerland)
Published: May 10, 2024
IFNα-induced BST2+ tumor-associated macrophages facilitate immunosuppression and tumor growth in pancreatic cancer by ERK-CXCL7 signaling.
Journal: Cell reports
Published: September 01, 2023
Histological tumor micronecrosis in resected specimens after R0 hepatectomy for hepatocellular carcinomas is a factor in determining adjuvant TACE: A retrospective propensity score-matched study.
Journal: International journal of surgery (London, England)
Published: April 29, 2022
Showing 1-11 of 11
Last Updated: 09/26/2026